AstraZeneca's Covid-19 vaccine gives promising results

[ollie989898]

Reuters | Breaking International News & Views

Find latest news from every corner of the globe at Reuters.com, your online source for breaking international news coverage.

uk.reuters.com

LONDON (Reuters) - The COVID-19 vaccine being developed by the University of Oxford produces a similar immune response in both older and younger adults, and adverse responses were lower among the elderly, British drug maker AstraZeneca Plc AZN.L said on Monday.

A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people, hammered the global economy and shuttered normal life across the world.

“It is encouraging to see immunogenicity responses were similar between older and younger adults and that reactogenicity was lower in older adults, where the COVID-19 disease severity is higher,” an AstraZeneca spokesman told Reuters.

“The results further build the body of evidence for the safety and immunogenicity of AZD1222,” the spokesman said, referring to the technical name of the vaccine.

The news that older people get an immune response from the vaccine is positive because the immune system weakens with age and older people are those most at risk of dying from the virus.

The Financial Times reported earlier that the vaccine, being developed by Oxford and AstraZeneca, triggers protective antibodies and T-cells in older age groups - among those most at risk from the virus.

The Oxford/AstraZeneca vaccine is expected to be one of the first from big pharma to secure regulatory approval, along with Pfizer PFE.N and BioNTech's 22UAy.F candidate.

The vaccine is likely to provide protection for about a year, CEO Pascal Soriot said in June.

The British drugmaker has signed several supply and manufacturing deals with companies and governments around the world as it gets closer to reporting early results of a late-stage clinical trial...

And people say the British don't design or manufacture anything....

 

[robs1]

Please dont promote anything the UK does, we are the pits all the worlds evils are down to u, well boris mainly closely followed by middle aged white brexit voters.

 

[bobk]

Reuters | Breaking International News & Views

Find latest news from every corner of the globe at Reuters.com, your online source for breaking international news coverage.

uk.reuters.com

LONDON (Reuters) - The COVID-19 vaccine being developed by the University of Oxford produces a similar immune response in both older and younger adults, and adverse responses were lower among the elderly, British drug maker AstraZeneca Plc AZN.L said on Monday.

A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people, hammered the global economy and shuttered normal life across the world.

“It is encouraging to see immunogenicity responses were similar between older and younger adults and that reactogenicity was lower in older adults, where the COVID-19 disease severity is higher,” an AstraZeneca spokesman told Reuters.

“The results further build the body of evidence for the safety and immunogenicity of AZD1222,” the spokesman said, referring to the technical name of the vaccine.

The news that older people get an immune response from the vaccine is positive because the immune system weakens with age and older people are those most at risk of dying from the virus.

The Financial Times reported earlier that the vaccine, being developed by Oxford and AstraZeneca, triggers protective antibodies and T-cells in older age groups - among those most at risk from the virus.

The Oxford/AstraZeneca vaccine is expected to be one of the first from big pharma to secure regulatory approval, along with Pfizer PFE.N and BioNTech's 22UAy.F candidate.

The vaccine is likely to provide protection for about a year, CEO Pascal Soriot said in June.

The British drugmaker has signed several supply and manufacturing deals with companies and governments around the world as it gets closer to reporting early results of a late-stage clinical trial...

And people say the British don't design or manufacture anything....

I've seen that , suspect if cases increase even more the vaccine could be rolled out pdq .

 

[Hindsight]

Please dont promote anything the UK does, we are the pits all the worlds evils are down to u, well boris mainly closely followed by middle aged white brexit voters.

Well indeed. Glad you appreciate same. Progress!! World puts those problems to one side and sympathizes with you and your ilk.

 

[upnortheast]

One of the better BBC jounos. Imo Fergus Walsh did a bit on it tonight. He said the vaccine would not get rid of the virus. It would most likely mean people would get much less severe symptoms.

 

[hoff135]

Coronavirus: UK only buying enough vaccines to protect the most vulnerable

The young and healthy should only get the jab after more analysis on the risks and benefits, according to advice.

news.sky.com

Younger people have been continually told that they are not immune to covid. I have seen the likes of Sturgeon insisting that young people must protect themselves. Yet it looks like they might not ever be offered a vaccine.

If thats the case then it pretty much nullifies the argument that young healthy people need to be careful for there own sake, because unless they live in the basement until they are 50 they are eventually going to get it.